Bayesian Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,100
| Closed | -$529K | – | 1108 |
|
|
2024
Q1 | $529K | Sell |
14,100
-400
| -3% | -$15K | 0.05% | 421 |
|
|
2023
Q4 | $811K | Buy |
14,500
+2,700
| +23% | +$151K | 0.09% | 277 |
|
|
2023
Q3 | $487K | Sell |
11,800
-8,200
| -41% | -$338K | 0.06% | 381 |
|
|
2023
Q2 | $1.12M | Buy |
+20,000
| New | +$1.12M | 0.12% | 232 |
|
|
2023
Q1 | – | Sell |
-13,407
| Closed | -$489K | – | 1096 |
|
|
2022
Q4 | $489K | Buy |
+13,407
| New | +$489K | 0.07% | 361 |
|